F8 and hemophilia: In particular, in patients affected by severe hemophilia (residual FVIII activity <1%) that require prophylactic administration of exogenous FVIII, the occurrence of neutralizing FVIII-specific IgG antibodies directed toward the infused clotting factor is frequent.